Kim et al demonstrated that that the sigmoid colon received the

Kim et al. demonstrated that that the sigmoid colon received the highest mean D2 when compared to the rectum and small bowel [28]. Their study

revealed that with the prescribed dose of 600 cGy, the sigmoid colon received the highest mean D2 (408 cGy) followed by the small bowel (379 cGy), and rectum (373 cGy). In our study, we clearly demonstrated that the small bowel D2 was higher than the sigmoid colon D2 (6.8 Gy and 6.5 Gy, respectively). We also found that the sigmoid colon D2 and D5 values were significantly higher with larger CTVs (Table 4). The small bowel D2 values were higher in group 2 than in group 1, and this difference was almost statistically CHIR98014 price significant (P = 0.07). The results of our study demonstrate that CT-guided BRT this website planning is superior to conventional point A planning in terms of both conformity of target coverage and evaluation of OARs, including the sigmoid colon, bowel, bladder, and rectum. Although this superiority was clear for small CTVs, for large CTVs both the conventional and CTV plans had the drawbacks of inadequate target coverage and/or excessive radiation doses to normal organs. To ascertain the potential benefit of treatment outcomes, such as tumor control probability and morbidity, ICR with image-guided 3D planning will be pursued and correlated with the

dose-volume parameters. Acknowledgements This study was accepted SAHA HDAC cell line as oral presentation at 7th Congress of Balkan Union of Oncology from 15 to 19 October 2008. References 1. Atahan PRKACG IL, Onal C, Ozyar E, Yiliz F, Selek U, Kose F: Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study. Int J Gynecol Cancer 2007, 17 (4) : 833–842.CrossRefPubMed 2. Nag S, Cardenes H, Chang S, Das IJ, Erickson

B, Ibbott GS, Lowenstein J, Roll J, Thomadsen B, Varia M: Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group. Int J Radiat Oncol Biol Phys 2004, 60 (4) : 1160–1172.CrossRefPubMed 3. Nag S: High dose rate brachytherapy: its clinical applications and treatment guidelines. Technol Cancer Res Treat 2004, 3 (3) : 269–287.PubMed 4. Viani GA, Manta GB, Stefano EJ, de Fendi LI: Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy – a meta-analysis of clinical trials. J Exp Clin Cancer Res 2009, 28: 47.CrossRefPubMed 5. ICRU Report no 38: Dose and volume specification for reporting intracavitary therapy in gynecology Bethesda, MD: International Commission on Radiation Units and Measurements; 1985. 6. Ling CC, Schell MC, Working KR, Jentzsch K, Harisiadis L, Carabell S, Rogers CC: CT-assisted assessment of bladder and rectum dose in gynecological implants. Int J Radiat Oncol Biol Phys 1987, 13 (10) : 1577–1582.CrossRefPubMed 7.

Comments are closed.